Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Generation Time01:22

Generation Time

Bacterial generation time, the period required for a bacterial population to double during its exponential growth phase, serves as a critical measure of microbial growth dynamics under optimal conditions. This parameter varies significantly across bacterial species and can be influenced by factors such as temperature, pH, and the availability of nutrients. For example, Escherichia coli can achieve a generation time of approximately 20 minutes, while Mycobacterium tuberculosis exhibits a much...
Emerging Adulthood01:27

Emerging Adulthood

Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during this...
Framing Effects03:26

Framing Effects

Information is everywhere and its presentation—such as how and when items are presented—can impact our perceptions and decisions surrounding the info. This broad concept umbrellas framing effects—influences that occur due to the way information is framed in its appearance, whether it’s purely the order or the specific wording of a message. Let’s take a look at numerous ways in which two versions of something can objectively say the same thing, yet we respond in different ways based on the...
Upward Impending Motion01:21

Upward Impending Motion

A square-threaded screw jack is a mechanical device widely used for lifting heavy loads or applying considerable force. Its operation is based on converting the force applied at its handle into a torsional moment, causing the upward impending motion of the screw. This movement is accomplished by overcoming the static friction between the threads of the screw and the jack.
To better comprehend how a screw jack functions, consider the completely unraveled thread as a block in contact with the...
Mixing Time01:19

Mixing Time

The concept of mixing time is significant in producing a uniform concrete mix with the required strength. The mixing period starts once all components are in the mixer. Initially, the mixer is charged with 10% of the water, followed by the consistent addition of solids and then 80% of the water. The remaining water is added later, within the first quarter of the mixing period. The minimum mixing time varies according to the mixer's capacity; for example, mixers with up to 1 cubic yard capacity...
Crossing over01:34

Crossing over

Unlike mitosis, meiosis aims for genetic diversity in its creation of haploid gametes. Dividing germ cells first begin this process in prophase I, where each chromosome—replicated in S phase—is now composed of two sister chromatids (identical copies) joined centrally.
The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process called synapsis.
In order to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

For Autoimmune Ills, Biologics Bring Promise-And Problems.

Managed care (Langhorne, Pa.)·2017
Same author

Biosimilar Research Proceeds in Cancer, RA, and Hep B.

Managed care (Langhorne, Pa.)·2016
Same author

Biosimilars in Development Near End of Phase 3 Trials.

Managed care (Langhorne, Pa.)·2016
Same author

Digital Health Technology Adoption Depends On Tech Comfort Level, Willingness to Pay.

Managed care (Langhorne, Pa.)·2016
Same author

New Cancer Drugs Shine, but Costs May Dim Luster.

Managed care (Langhorne, Pa.)·2015
Same author

Sure, They're Cool, but Will Smart Wearables Ever Live Up to Their Potential?

Managed care (Langhorne, Pa.)·2015
Same journal

Big pharma moves into biologics.

Biotechnology healthcare·2013
Same journal

Study: High Copayments Cut Biodrug Use up to 21 Percent.

Biotechnology healthcare·2013
Same journal

Avian flu and the quest for immunity: not just chicken feed.

Biotechnology healthcare·2013
Same journal

Variety of Biotech Therapies, Uses Take Prominence Among ASCO Presentations.

Biotechnology healthcare·2013
Same journal

Opening the door to follow-on proteins?

Biotechnology healthcare·2013
Same journal

On specialty pharmaceuticals: reflections of a second-year medical student.

Biotechnology healthcare·2013
See all related articles

Related Experiment Video

Updated: May 23, 2026

Micro-scale Engineering for Cell Biology
04:42

Micro-scale Engineering for Cell Biology

Published on: October 1, 2007

A century in the making… almost here?

Katherine T Adams

    Biotechnology Healthcare
    |April 6, 2012
    PubMed
    Summary
    This summary is machine-generated.

    Cancer immunotherapeutics, including vaccines, are nearing market availability, offering improved survival and remission. These advancements promise a better cost-benefit ratio and may transform healthcare delivery and financing.

    More Related Videos

    Sediment Core Extrusion Method at Millimeter Resolution Using a Calibrated, Threaded-rod
    06:06

    Sediment Core Extrusion Method at Millimeter Resolution Using a Calibrated, Threaded-rod

    Published on: August 17, 2016

    Investigating the Microbial Community in the Termite Hindgut - Interview
    21:02

    Investigating the Microbial Community in the Termite Hindgut - Interview

    Published on: May 28, 2007

    Related Experiment Videos

    Last Updated: May 23, 2026

    Micro-scale Engineering for Cell Biology
    04:42

    Micro-scale Engineering for Cell Biology

    Published on: October 1, 2007

    Sediment Core Extrusion Method at Millimeter Resolution Using a Calibrated, Threaded-rod
    06:06

    Sediment Core Extrusion Method at Millimeter Resolution Using a Calibrated, Threaded-rod

    Published on: August 17, 2016

    Investigating the Microbial Community in the Termite Hindgut - Interview
    21:02

    Investigating the Microbial Community in the Termite Hindgut - Interview

    Published on: May 28, 2007

    Area of Science:

    • Oncology
    • Immunology
    • Healthcare Economics

    Background:

    • Current cancer treatments (oncologics) are often costly and may not provide long-term remission.
    • The field of cancer immunotherapy is rapidly advancing, with novel therapeutic approaches emerging.

    Purpose of the Study:

    • To highlight the potential market entry of cancer immunotherapeutics, including vaccines, within the decade.
    • To discuss the anticipated benefits of these new therapies, such as extended survival and remission.
    • To explore the potential impact on healthcare delivery and financing models.

    Main Methods:

    • This abstract is a projection based on current trends in cancer research and development.
    • It synthesizes information on the expected timeline for immunotherapeutic market entry.
    • It analyzes the projected cost-benefit implications and healthcare system impacts.

    Main Results:

    • Cancer immunotherapeutics, including vaccines, are anticipated to become available by the end of the current decade.
    • These therapies are expected to offer longer patient survival and potentially indefinite remission.
    • A more favorable cost-benefit ratio compared to existing oncologics is projected.

    Conclusions:

    • Cancer immunotherapeutics represent a significant upcoming advancement in oncology.
    • These treatments are poised to improve patient outcomes and potentially reduce long-term healthcare costs.
    • The integration of immunotherapeutics may necessitate significant changes in healthcare delivery and financing.